Is Cytokinetics, Incorporated (CYTK) A Good Stock To Buy Now?
Is CYTK a good stock to buy? We came across a bullish thesis on Cytokinetics, Incorporated on TradersPro’s Substack.
Posts Tagged ‘NASDAQ:CYTK’
10 Most Promising Mid-Cap Stocks to Buy According to Analysts
On June 9, Liz Ann Sonders, Charles Schwab, joined 'Closing Bell' on CNBC to discuss the recent market movements, suggesting that the recent sell-off helped alleviate some of ...
Citi Calls Cytokinetics, Incorporated (CYTK) a “Top Pick” Among Small-to-Mid Cap Biotech Stocks
Cytokinetics, Incorporated (NASDAQ:CYTK) is one of the best momentum stocks to buy according to analysts. Citi initiated coverage of Cytokinetics, Incorporated (NASDAQ:CYTK) ...
10 Best Momentum Stocks to Buy According to Analysts
On May 22, Steve Sosnick, from Interactive Brokers, appeared on CNBC’s ‘Power Lunch’ to talk about what is driving the record market moves.
Cytokinetics, Incorporated (NASDAQ:CYTK) Q1 2026 Earnings Call Transcript
Cytokinetics, Incorporated (NASDAQ:CYTK) Q1 2026 Earnings Call Transcript May 5, 2026Cytokinetics, Incorporated reports earnings inline with expectations.
10 Stocks Turning Heads With Double-Digit Gains
The stocks mirrored a broader market optimism, with Wall Street’s three major indices finishing in the green.
Cytokinetics, Incorporated (NASDAQ:CYTK) Q4 2025 Earnings Call Transcript
Cytokinetics, Incorporated (NASDAQ:CYTK) Q4 2025 Earnings Call Transcript February 24, 2026Cytokinetics, Incorporated misses on earnings expectations.
Cytokinetics, Incorporated (CYTK) Poised for Market Share Gain with Myqorzo in Cardiac Myosin Space
Cytokinetics (NASDAQ:CYTK) is one of the best debt-free mid-cap stocks to buy according to hedge funds. On February 4, B.
10 Best Debt-Free Mid-Cap Stocks to Buy According to Hedge Funds
Mid-cap stocks are poised for an impressive run heading into the US midterm election.
Truist Notes Operational Investments For Cytokinetics, Incorporated (CYTK) to Support Short-Term Growth
TheFly reported on February 3 that Truist raised its price target on CYTK to $92 from $84 and maintained a Buy rating. The company revised its model ahead of its Q4 results...
15 Innovative Healthcare Stocks to Buy According to Analysts
Over the last two years, artificial intelligence has propelled global financial markets into a boom, with stocks reaching all-time highs.
Cytokinetics, Incorporated (CYTK): A Bull Case Theory
We came across a bullish thesis on Cytokinetics, Incorporated on Valueinvestorsclub.com by Bohr. In this article, we will summarize the bulls’ thesis on CYTK.
Cytokinetics, Incorporated (NASDAQ:CYTK) Q3 2025 Earnings Call Transcript
Operator: Thank you for standing by, and welcome to the Cytokinetics Q3 2025 Earnings Conference Call.
Cytokinetics (CYTK) Drops on $650-Million Debt Issuance
In a statement, Cytokinetics, Inc. (NASDAQ:CYTK) said it aimed to raise $650 million from the offer, an increase from the $550 million targeted initially.
Cytokinetics (CYTK) Rockets 40.45% as Aficamten Results Promising
Cytokinetics snapped a two-day losing streak on Tuesday, soaring 40.45 percent to close at $49.62 apiece as investors cheered promising results from its study of Aficamten, its...
Citi Lowers Cytokinetics (CYTK) PT to $77 Due to Uneventful Q2 2025 Earnings
Cytokinetics Incorporated (NASDAQ:CYTK) is one of the best upside stocks to invest in now.
Cytokinetics, Incorporated (NASDAQ:CYTK) Q2 2025 Earnings Call Transcript
Operator: Thank you for standing by. My name is Prilla, and I will be your conference operator today. Welcome to the Cytokinetics Q2 2025 Earnings Conference Call.
Cytokinetics to Present New Aficamten Data at ESC Congress 2025
Cytokinetics Incorporated (NASDAQ:CYTK) is one of the biotech stocks to buy according to Wall Street analysts.
10 Biotech Stocks to Buy According to Wall Street Analysts
On July 8, Jared Holz, Mizuho, joined 'Closing Bell Overtime' on CNBC to discuss if the biotech sector is ready for a breakout.
Piper Sandler Maintains a Buy Rating on Cytokinetics (CYTK) With a $107 PT
Cytokinetics, Incorporated (NASDAQ:CYTK) is one of the 13 Best Pharma Stocks to Buy According to Wall Street Analysts.
13 Best Pharma Stocks to Buy According to Wall Street Analysts
On June 24, Jared Holz, Mizuho's healthcare strategist, appeared on CNBC's 'Fast Money' to talk about competition in the obesity drug space.
Cytokinetics Presents Positive Aficamten Data for Obstructive HCM at European Heart Failure Congress
Cytokinetics Incorporated (NASDAQ:CYTK) is one of the most active stocks to buy according to analysts.
11 Best Most Active Stocks To Buy According to Analysts
The Co-Chief Investment Strategist at John Hancock Investment Management, Emily Roland, believes that we're in a period of serious disinflation.
Cytokinetics, Incorporated (CYTK) Price Target Lowered To $53 from $71 at JPMorgan
Cytokinetics, Incorporated (NASDAQ:CYTK) is one of the 13 Biotech Stocks with Huge Upside Potential.
13 Biotech Stocks with Huge Upside Potential
The FDA Commissioner Marty Makary stated the FDA will reach its 2025 drug approval targets despite severe workforce reductions.
Cytokinetics, Incorporated (NASDAQ:CYTK) Q1 2025 Earnings Call Transcript
Operator: Good afternoon, and welcome to Cytokinetics' First Quarter 2025 Conference Call. At this time, I would like to inform you that this call is being recorded.
10 Best High Short Interest Stocks to Buy Now
Aditya Bhave, BofA Securities head of US Economics, joined 'Power Lunch' on CNBC on April 17 to talk about whether tariffs are ultimately inflationary, disinflationary, or deflationary...
10 Best Mid Cap Biotech Stocks to Buy
On March 6, Jared Holz, Mizuho health care equity strategist, appeared on CNBC's 'Power Lunch' to discuss investing in biotech and the oversaturation in the sector.
12 Most Promising Biotech Stocks According to Wall Street Analysts
The biotechnology sector is gaining new momentum with better market conditions, cutting-edge innovations, and growing investor attention.
Cytokinetics, Incorporated (NASDAQ:CYTK) Q4 2024 Earnings Call Transcript
Cytokinetics, Incorporated (NASDAQ:CYTK) Q4 2024 Earnings Call Transcript February 27, 2025Cytokinetics, Incorporated beats earnings expectations.
10 Oversold Pharma Stocks to Buy According to Analysts
On February 20, Emily Field, Head of European Pharma Research at Barclays, appeared on CNBC to discuss the dynamics of the pharmaceutical sector, the impact of US tariffs, and...
12 Most Oversold Healthcare Stocks to Buy Now
Healthcare costs and spending have been rising in the US.
12 Best Healthcare Stocks to Buy According to Analysts
McKinsey reported that, since 2019, the US healthcare industry witnessed significant financial pressure.
10 Stocks That Analysts Are Talking About
Like any other informed investor, we are always on the hunt for stocks that analysts are talking about.
10 Worst Performing Biotech Stocks in 2024
Biotechnology stocks are among the most volatile in the market due to their high risk.
Cytokinetics, Incorporated (NASDAQ:CYTK) Q3 2024 Earnings Call Transcript
Cytokinetics, Incorporated (NASDAQ:CYTK) Q3 2024 Earnings Call Transcript November 6, 2024Cytokinetics, Incorporated misses on earnings expectations.
10 Most Promising Biotech Stocks According to Hedge Funds
Biotechnology stocks are known for their high risk, making them some of the most volatile in the market.
7 Best Small Company Stocks To Invest In
The Fed's decision to cut interest rates by 50 basis points in September significantly impacted the market.
Is Cytokinetics, Incorporated (NASDAQ:CYTK) the Best Mid-Cap Healthcare Stock To Buy Now?
We recently compiled a list of the 7 Best Mid-Cap Healthcare Stocks To Buy Now and in this article we discuss whether Cytokinetics, Incorporated (NASDAQ:CYTK) is the best mid-...
7 Best Mid-Cap Healthcare Stocks To Buy Now
The healthcare industry is considered to be a fairly defensive sector due to its need.
Cytokinetics, Incorporated (NASDAQ:CYTK) Q1 2024 Earnings Call Transcript
Operator: Good afternoon. And welcome ladies and gentlemen to Cytokinetics First Quarter 2024 Conference Call.
30 Biggest Biotechnology Companies in the World
In this article, we will be taking a look at the 30 biggest biotechnology companies in the world.
Cytokinetics, Incorporated (NASDAQ:CYTK) Q4 2023 Earnings Call Transcript
Cytokinetics, Incorporated misses on earnings expectations. Reported EPS is $-1.38 EPS, expectations were $-1.03.
5 Best Russell 2000 Stocks To Buy According To Hedge Funds
In this article, we discuss 5 best Russell 2000 stocks to buy.
Cytokinetics, Incorporated (CYTK) Rose on Successful Clinical Trial
Carillon Tower Advisers, an investment management company, released its “Carillon Eagle Small Cap Growth Fund” fourth quarter 2023 investor letter.
11 Most Promising Biotech Stocks to Buy According to Analysts
In this article, we will take a look at the 11 most promising biotech stocks to buy according to analysts.
12 Best Small-Cap Biotech Stocks with Massive Potential According to Hedge Funds
In this article we present the list of 12 Best Small-Cap Biotech Stocks with Massive Potential According to Hedge Funds.
Cytokinetics, Incorporated (NASDAQ:CYTK) Q3 2023 Earnings Call Transcript
Operator: Good afternoon, and welcome, ladies and gentlemen, to Cytokinetics Third Quarter 2023 Conference Call.
10 Biotech Stocks with Biggest Upside
In this article, we discuss 12 biotech stocks with biggest upside.
15 Worst Performing Biotech Stocks in 2023
In this article, we discuss 15 worst performing biotech stocks in 2023.
Hedge Fund Resource Center
